Michael Friedman

Michael Friedman, MD, is a former director at Celgene Corporation and currently a director of Intuitive Surgical Inc., has held several roles, including CEO and the Irell & Manella Cancer Center Director’s Distinguished Chair, at City of Hope cancer treatment and research center, where he is currently emeritus director of the cancer center. His work experience also includes serving as acting commissioner of the US Food and Drug Administration.

Dr Friedman has authored more than 150 scientific papers and book chapters. His commendations include the 1999 Surgeon General’s Medallion. Dr Friedman received his doctorate in medicine from the University of Texas Southwestern Medical and completed his postdoctoral training at Stanford University and the National Cancer Institute. Dr Friedman is board-certified in internal medicine and medical oncology.